Sema4 agrees to acquire GeneDx from OPKO for $150M cash + 80M shares; $200M PIPE at $4.00/share

GeneDx Holdings Corp.

Total consideration: $150M cash + 80M Sema4 shares + up to $150M in revenue-based milestones.
GeneDx CEO Katherine Stueland will become Co-CEO of Sema4 post-close; Jason Ryan named Executive Chair.
PIPE of $200M (50M shares at $4.00/share) from institutional investors, including existing holders.
Closing expected in H1 2022, subject to stockholder approval, HSR, and other customary conditions.
OPKO and certain holders subject to 1-year lock-up on stock consideration; support agreements for voting.

item 1.01 item 3.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Keith Meister

Director

WGS · GeneDx Holdings Corp.

Effective: 2022-01-14
Filed: January 18, 2022, 6:59 PM ET

Keith Meister was appointed to the Board as a director of the Company

Role change

Jason Ryan

Executive Chairperson of the Board

WGS · GeneDx Holdings Corp.

Effective: 2022-01-18
Filed: January 18, 2022, 6:59 PM ET

the Board approved the appointment of Jason Ryan, a current director of the Company, as the Executive Chairperson of the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Keith Meister was appointed as Director at GeneDx Holdings Corp..

Action: appointed
Role: Director

Exact text from the filing

Keith Meister was appointed to the Board as a director of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Ryan was appointed as Executive Chairperson of the Board at GeneDx Holdings Corp..

Action: appointed
Role: Executive Chairperson of the Board

Exact text from the filing

the Board approved the appointment of Jason Ryan, a current director of the Company, as the Executive Chairperson of the Board

View on SEC.gov

GeneDx Holdings Corp. filing history →

Source: SEC EDGAR

accession 0001818331-22-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.